Patent · US Active

Method for the preparation of 2′-deoxy-2′,2′-difluorocytidine

US7799907B2 · kind B2 · utility

0Cited by
6References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2005
Grant dateSep 21, 2010
Priority date
Expiry dateMar 5, 2027

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided is an improved method for stereoselectively preparing 2′-deoxy-2′,2′-difluorocytidine of formula (I), which includes reacting a 1-halo ribofuranose compound with a nucleobase of formula (IV) in a solvent to obtain a nucleo side of formula (II) with removal of a silyl halide ((alkyl)3SiX (X=halide)); and deprotecting the nucleoside of formula (II) to obtain 2′-deoxy-2′,2′-difluorocytidine of formula (I). 2′-Deoxy-2′,2′-difluorocytidine of formula (I) is effective for treating various cancers such as non-small cell lung (NSCLC), pancreatic, bladder, breast or ovarian cancers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.